GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » MARX Biotech Co Ltd (ROCO:7731) » Definitions » EV-to-Revenue

MARX Biotech Co (ROCO:7731) EV-to-Revenue : (As of Jun. 23, 2024)


View and export this data going back to 2024. Start your Free Trial

What is MARX Biotech Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, MARX Biotech Co's enterprise value is NT$4,530.8 Mil. MARX Biotech Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was NT$0.0 Mil. Therefore, MARX Biotech Co's EV-to-Revenue for today is .

The historical rank and industry rank for MARX Biotech Co's EV-to-Revenue or its related term are showing as below:

ROCO:7731' s EV-to-Revenue Range Over the Past 10 Years
Min: 0   Med: 0   Max: 0
Current: 40.95

ROCO:7731's EV-to-Revenue is ranked worse than
95.96% of 669 companies
in the Healthcare Providers & Services industry
Industry Median: 1.77 vs ROCO:7731: 40.95

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-23), MARX Biotech Co's stock price is NT$18.80. MARX Biotech Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was NT$0.00. Therefore, MARX Biotech Co's PS Ratio for today is .


MARX Biotech Co EV-to-Revenue Historical Data

The historical data trend for MARX Biotech Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MARX Biotech Co EV-to-Revenue Chart

MARX Biotech Co Annual Data
Trend Dec20 Dec21 Dec22
EV-to-Revenue
- - -

MARX Biotech Co Quarterly Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-Revenue Get a 7-Day Free Trial - - - - -

Competitive Comparison of MARX Biotech Co's EV-to-Revenue

For the Pharmaceutical Retailers subindustry, MARX Biotech Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MARX Biotech Co's EV-to-Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, MARX Biotech Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where MARX Biotech Co's EV-to-Revenue falls into.



MARX Biotech Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

MARX Biotech Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=4530.789/0
=

MARX Biotech Co's current Enterprise Value is NT$4,530.8 Mil.
MARX Biotech Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MARX Biotech Co  (ROCO:7731) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

MARX Biotech Co's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=18.80/0
=

MARX Biotech Co's share price for today is NT$18.80.
MARX Biotech Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MARX Biotech Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of MARX Biotech Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


MARX Biotech Co (ROCO:7731) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
5th Floor, No. 655, Bannan Road, Zhonghe district, New Taipei, TWN
MARX Biotech Co Ltd is a retail company which has developed an O2O and OMO full-channel layout in the online Internet platform and cosmeceutical retail market, and has successfully established itself in the market and Build trust and operational growth on the channel side. It has has established more than three thousand large and small cosmeceutical pharmacies in Taiwan, including: Dashu Pharmacy, Dingding Pharmacy, Cosmed, Watsons, Spring Pharmacy, New Gaoqiao Pharmacy, Anlier Pharmacies, etc.

MARX Biotech Co (ROCO:7731) Headlines

No Headlines